Related Experiment Video
Updated: Jul 23, 2026
An In Vitro Model to Study the Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy on Staphylococcus aureus Biofilm
Published on: April 16, 2018
Evaluating the Impact of Febuxostat on 5-Aminolevulinic Acid-Based Photodynamic Therapy in Bladder Cancer Cell Lines
Fatemeh Khatami1, Hossein Sharifkazemi2, Diana Taheri3
1Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Background:
Bladder cancer (BC) is a prevalent malignancy worldwide, with significant challenges in recurrence management following conventional treatments. This study investigates the potential of Febuxostat, an established xanthine oxidase inhibitor, to enhance the efficacy of photodynamic therapy (PDT) utilizing 5-aminolevulinic acid (5-ALA) in bladder cancer cell lines T24 and 5637.
Methods:
In this in vitro study, we evaluated the effect of 5-ALA, Febuxostat and 5-ALA- Febuxostat combination therapy in T24 and 5637 cell lines as representatives of human bladder cancer. The assessment includes scratch-wound assay, colony formation assay, ROS measurement, flow cytometric analysis of apoptosis and DNA cell cycle, real-time PCR (BAX/BCL2, E-cadherin, N-cadherin, HIF1α and VEGFC genes).
Results:
Our findings demonstrate that co-administration of Febuxostat significantly increases ROS output compared to ALA treatment alone (p-value ≤ 0.05), leading to enhanced cytotoxicity and apoptosis. Flow cytometric analyses revealed elevated apoptosis rates in combination treatment groups, and cell cycle assessments indicated a preferential sub-G1 phase arrest associated with the enhanced apoptotic response (P Value = 0.03). Additionally, gene expression profiling showed alterations in key apoptotic markers (BAX/BCL2), with an upregulation of pro-apoptotic genes and a downregulation of anti-apoptotic factors and increase E-Cadherin/N-Cadherin in response to Febuxostat-enhanced PDT (P Value>0.05).
Conclusion:
These results indicate that Febuxostat effectively potentiates the photodynamic effects of ALA in bladder cancer cells, promising a novel therapeutic strategy that warrants further exploration.
